Top of this page
Skip navigation, go straight to the content
Scroll down to discover UCB
EVENITY® (Romosozumab)
| Disease area studied |
Abbreviated title | Phase | Study ID | Registry database | Study results | Lay summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
Osteoporosis postmenopausal |
European non-interventional post-authorization safety study related to serious cardiovascular events of myocardial infarction and stroke, and all-cause mortality for romosozumab by the EU-ADR Alliance |
OP0004 Ongoing |
EUPAS35881 | ||||
| Osteoporosis postmenopausal | European non-interventional post-authorization safety study related to adherence to the risk minimization measures for romosozumab by the EU-ADR Alliance |
OP0005 Ongoing |
EUPAS35956 | ||||
| Osteoporosis postmenopausal | European non-interventional post-authorization safety study related to serious infections for romosozumab by the EU-ADR Alliance |
OP0006 Ongoing |
EUPAS36005 |
|